EZ-editor™ platform, large-scale cell resources, and standardised workflows support faster and more reliable knockout ...
Gene and cell therapy is moving fast – and in a clear direction. Programs are pushing toward more complex payloads, virus-free engineering, and manufacturing models that can scale from early research ...
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced ...
In a recent article in Molecular Therapy, Sanofi presented preclinical data for an in vivo CAR-T platform that reengineers T ...
Silicon nanotube arrays deliver functional mRNA into human pluripotent stem cells for the first time, achieving up to 64% transfection without compromising stem cell identity.
A new 96-well electroporation platform streamlines cell transfection for research and drug discovery. It processes up to 96 samples in a single run, improving experimental consistency, workflow ...
The annual, future-facing awards showcase the next generation of high-potential founders and technically ambitious ventures emerging from Cambridge and the wider East of England. This year’s Top21 ...
Successful production of high titers of adeno-associated virus (AAV) vector at a large scale is a race against time. During AAV manufacturing, a transfection complex made up of plasmid DNA (pDNA) and ...
Article subjects are automatically applied from the ACS Subject Taxonomy and describe the scientific concepts and themes of the article. In this study, we developed a fluorinated dendrimer exhibiting ...
Modifying gene-delivery approaches for lymphocytes is critical for both fundamental research and clinical immunotherapy. T cells, B cells, and natural killer (NK) cells are difficult to transfect, and ...
This research investigates how to optimize mRNA transfection in human T-cells utilizing the jetMESSENGER ® transfection reagent. By using advanced bioanalytical instruments like the Incucyte ® ...